Carvedilol
Who holds supplier records for Carvedilol? 23 organisations hold a current record for Carvedilol: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 17 of them hold a valid EU Certificate of Suitability (18 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (15), Spain (1), Netherlands (1), Poland (1) and 5 other countries (5).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Carvedilol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/carvedilol
Reading the evidence
- 23 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
15 of the 23 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Carvedilol expires 11 Mar 2026. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (23)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Carvedilol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19106 · latest filing Jan 2006
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 18515, 28139 · latest filing Apr 2014
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 20930 · latest filing Oct 2007
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 18499 · latest filing Jul 2005
- MOEHS IBERICA SLSpainCEPActive DMF 16044 · latest filing Jul 2002
- SHODHANA LABORATORIES LTDIndiaCEPActive DMF 39938 · latest filing May 2024
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 17590 · latest filing Aug 2004
- TAPI NL BVNetherlandsCEPActive DMF 15865 · latest filing Feb 2002
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 17060 · latest filing Dec 2003
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 19533 · latest filing Jun 2006
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 17947 · latest filing Dec 2004
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 41605 · latest filing Mar 2025
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 24096 · latest filing Aug 2010
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 16330 · latest filing Jan 2003
- Lupin LimitedIndia Company GMP cert on recordActive DMF 19218 · latest filing Feb 2006
- RAKS PHARMA PVT LTDIndiaActive DMF 23743 · latest filing Apr 2010
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 18145 · latest filing Mar 2005
- Cipla LimitedIndiaCEP Company GMP cert on recordInactive DMF 17187 · latest filing Feb 2004
- IndiaCEP
- HungaryCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- KRKA TOVARNA ZDRAVIL D.D.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- F Hoffmann-La Roche Ltd.SwitzerlandCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (18)
Certificates of Suitability on the EDQM register for Carvedilol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 27 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto | SI | CEP 2001-294 - Rev 05 Carvedilol | Jul 2026 | Inspected Jul 2025 Slovenia |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2019-239 - Rev 02 Carvedilol | Jul 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2005-267 - Rev 08 Carvedilol | Jun 2026 | — |
| ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski | PL | CEP 2002-258 - Rev 10 Carvedilol | Apr 2026 | Inspected Jul 2026 Poland |
| EGIS PHARMACEUTICALS PLC. Budapest X | HU | CEP 2016-314 - Rev 01 Carvedilol, Synthetic route B | Apr 2026 | Inspected Nov 2025 Hungary |
| MOEHS IBERICA S.L. Rubi | ES | CEP 2002-089 - Rev 04 Carvedilol | Oct 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2003-048 - Rev 07 Carvedilol | Jul 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2024-534 - Rev 00 Carvedilol, Process-II, micronised | Feb 2025 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | CEP 2014-201 - Rev 02 Carvedilol | Jan 2025 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R0-CEP 2021-109 - Rev 00 Carvedilol | May 2023 | — |
| SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad | IN | R1-CEP 2008-259 - Rev 01 Carvedilol | Jul 2022 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2004-287 - Rev 05 Carvedilol | Jul 2021 | — |
| IPCA Laboratories Limited Mumbai | IN | R1-CEP 2007-298 - Rev 01 Carvedilol | Jun 2019 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | R1-CEP 2003-042 - Rev 03 Carvedilol | Feb 2019 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2005-124 - Rev 03 Carvedilol | Mar 2018 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2004-230 - Rev 05 Carvedilol | Jul 2015 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | R1-CEP 2006-083 - Rev 01 Carvedilol | Nov 2013 | — |
| F Hoffmann-La Roche Ltd. Basel | CH | R1-CEP 2002-001 - Rev 03 Carvedilol | Jul 2012 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Carvedilol are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- India · Inactive DMF 22043 · filed Sept 2008
- ROCHE DIAGNOSTICS GMBHInactive DMF 20587 · filed Jun 2007
- India · Inactive DMF 20308 · filed Feb 2007
- United States · Inactive DMF 19936 · filed Nov 2006
- ORCHID CHEMICALS AND PHARMACEUTICALS LTDInactive DMF 19373 · filed Apr 2006
- URQUIMA SAInactive DMF 18158 · filed Mar 2005
- India · Inactive DMF 17487 · filed Jun 2004
- Inactive DMF 17405 · filed May 2004
- Czechia · Inactive DMF 16530 · filed Apr 2003
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (56 listed products contain Carvedilol). The latest listed patent expires 11 Mar 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Carvedilol is a non-selective beta blocker with alpha-1 blocking activity primarily used for the treatment of mild to moderate congestive heart failure and hypertension. It helps to decrease heart rate and dilate blood vessels to improve blood flow.
Chemical identity
- IUPAC name
- 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
- Canonical SMILES
- COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
- InChIKey
- OGHNVEJMJSYVRP-UHFFFAOYSA-N
- Synonyms
- Carvedilol, Coreg, artist, bm 14.190, bm-14-190, bm-14.190, bm-14190, c07ag02, coronis, dilatrend, dimitone, dq-2466
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- alpha-Adrenergic Blocker; beta-Adrenergic Blocker
- Mechanism of action
- Adrenergic alpha-Antagonists; Adrenergic beta1-Antagonists; Adrenergic beta2-Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Carvedilol?
23 organisations hold an active US FDA Type II Drug Master File or a CEP for Carvedilol: APITORIA PHARMA PRIVATE LTD (India), Cadila Pharmaceuticals Limited (India), Ipca Laboratories Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MOEHS IBERICA SL (Spain), SHODHANA LABORATORIES LTD (India), Sun Pharmaceutical Industries Limited (India) and TAPI NL BV (Netherlands), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Carvedilol Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 19106), Cadila Pharmaceuticals Limited (DMF 18515, 28139), Ipca Laboratories Limited (DMF 20930), MATRIX PHARMACORP PRIVATE LTD (DMF 18499), MOEHS IBERICA SL (DMF 16044), SHODHANA LABORATORIES LTD (DMF 39938), Sun Pharmaceutical Industries Limited (DMF 17590) and TAPI NL BV (DMF 15865) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Carvedilol records mean?
9 organisations have only inactive Type II DMFs for Carvedilol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Carvedilol have a European Certificate of Suitability?
Yes. 17 organisations hold a valid CEP for Carvedilol on the EDQM register, including KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski (PL), EGIS PHARMACEUTICALS PLC. Budapest X (HU) and MOEHS IBERICA S.L. Rubi (ES) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Carvedilol?
Yes. The latest patent listed for an approved US product containing Carvedilol expires 11 Mar 2026, across 56 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Carvedilol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Carvedilol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.